Krystal Biotech, Inc. KRYS Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $204.83M+130% | $89.16M+716% | $10.93M+108% | -$139.98M-101% | ||
| $5.67M-3.7% | $5.89M+6.3% | $5.54M+36.7% | $4.06M+46.4% | ||
| $54.51M+11.0% | $49.13M+23.0% | $39.93M+20.2% | $33.23M+117% | ||
| —— | $68.65M+63.3% | $42.04M— | —— | ||
| —— | $12.44M+178% | $4.48M— | —— | ||
| —— | —— | -$101K+91.9% | -$1.25M-276% | ||
| $15.4M— | —— | $4.56M-11.9% | $5.17M— | ||
| —— | —— | $64K-57.3% | $150K+331% | ||
| $2.28M+60.7% | $1.42M— | —— | $0— | ||
| —— | —— | $217K+538% | $34K+107% | ||
| $827K+10.7% | $747K-17.4% | $904K+21.8% | $742K— | ||
| $200.87M+57.4% | $127.59M+244% | -$88.8M+11.7% | -$100.57M-110% | ||
| $11.95M+182% | $4.24M-64.1% | $11.8M-77.7% | $52.98M-22.5% | ||
| $422.54M-7.7% | $457.74M-10.0% | $508.78M+59.6% | $318.78M+67.4% | ||
| $375.64M+25.8% | $298.54M-40.7% | $503.21M+95.3% | $257.68M+705% | ||
| —— | $0— | $0— | —— | ||
| —— | -$163.44M— | —— | -$114.08M+49.7% | ||
| $0— | $0-100% | $159.85M— | —— | ||
| —— | —— | —— | —— | ||
| —— | $27.01M-86.7% | $202.75M+474% | $35.35M-89.8% | ||
| —— | -$458K— | —— | -$41K— | ||
| $151.44M+1,225% | -$13.46M-106% | $211.34M+218% | -$179.35M— | ||
| $15.67M+177% | $5.67M— | —— | $0— | ||
| -$498K+70.8% | -$1.71M+21.9% | -$2.18M-426% | $670K— | ||
| $5.67M-3.7% | $5.89M+17.4% | $5.02M+89.8% | $2.64M+42.9% | ||
| —— | $31.25M— | $0— | —— | ||
| $15.4M— | —— | $4.56M-11.9% | $5.17M— | ||
| $21.27M-31.0% | $30.83M+416% | $5.98M— | $0— | ||
| -$578K+30.6% | -$833K-0.5% | -$829K-28.1% | -$647K-127% | ||
| $2.28M+60.7% | $1.42M— | —— | $0— | ||
| —— | $7.82M— | —— | $615K-11.0% | ||
| —— | —— | $0— | —— | ||
| $827K+10.7% | $747K-17.4% | $904K+21.8% | $742K— | ||
| $5.95M-1.9% | $6.07M+19.2% | $5.09M+793% | $570K— | ||
| —— | $298.54M-40.7% | $503.21M+95.3% | $257.68M+705% | ||
| —— | $0— | $0— | —— | ||
| —— | $8.77M— | —— | —— | ||
| —— | $0— | $0— | —— | ||
| $188.91M+51.8% | $124.48M+224% | -$100.6M+34.5% | -$153.55M-32.1% | ||
| $188.91M+51.8% | $124.48M+224% | -$100.6M+34.5% | -$153.55M-32.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Krystal Biotech, Inc. generate?
- Krystal Biotech, Inc. (KRYS) generated $250.3M in operating cash flow over the trailing twelve months.
- What is Krystal Biotech, Inc.'s free cash flow?
- After $12.9M of capital expenditures, Krystal Biotech, Inc.'s free cash flow was $237.4M over the trailing twelve months, up 76.3% year over year.
- Where does Krystal Biotech, Inc.'s cash flow data come from?
- Every line is extracted from Krystal Biotech, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
